Literature DB >> 30121314

Protective Efficacy of Candidate Vaccines Prior to Human Clinical Trials.

Ali Azizi1.   

Abstract

Immunization of animals is one of the key standards for evaluation of vaccine efficacy prior to human clinical trials. However, vaccine organizations should not over-interpret these results as protective efficacy in animals may not be relevant in humans. Screening of vaccine candidates has recently been performed by several in vitro human models. A properly designed in vitro approach opens new venues for vaccine development.
Copyright © 2018 American Pharmacists Association®. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  animal models; human trials; in vitro human screening; protective efficacy; regulatory guidelines; vaccines

Mesh:

Substances:

Year:  2018        PMID: 30121314     DOI: 10.1016/j.xphs.2018.08.005

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  1 in total

1.  An Analytically and Diagnostically Sensitive RNA Extraction and RT-qPCR Protocol for Peripheral Blood Mononuclear Cells.

Authors:  Daniel J Browne; Jamie L Brady; Ashley J Waardenberg; Claire Loiseau; Denise L Doolan
Journal:  Front Immunol       Date:  2020-03-20       Impact factor: 7.561

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.